Federal Reserve cuts interest rates in modest win for biotechnews2025-09-17T19:45:03+00:00September 17th, 2025|Endpoints News|
Regeneron heads to FDA with treatment for very rare bone diseasenews2025-09-17T19:31:06+00:00September 17th, 2025|Endpoints News|
#EADV25: Next-gen psoriasis drugs seek to challenge existing treatment optionsnews2025-09-17T15:11:27+00:00September 17th, 2025|Endpoints News|
X4 Pharmaceuticals restructures; Cytokinetics targets $650M raisenews2025-09-17T14:42:49+00:00September 17th, 2025|Endpoints News|
AGC Bio to sell two sites in Colorado, will lay off 278 workers in the processnews2025-09-17T14:41:51+00:00September 17th, 2025|Endpoints News|
#EADV25: Leo Pharma details mid-stage win for IL-22 targeting antibody in atopic dermatitisnews2025-09-17T14:00:38+00:00September 17th, 2025|Endpoints News|
Joe Jimenez’s new biotech inks up to $1B biobuck deal for Mabwell’s cardio siRNAnews2025-09-17T13:32:58+00:00September 17th, 2025|Endpoints News|
Monarez updates: Ousted CDC director testifies before Senate health committeenews2025-09-17T13:30:32+00:00September 17th, 2025|Endpoints News|
Lilly’s diabetes pill beats Novo’s Rybelsus in head-to-head trial, company mulls fast-track filingnews2025-09-17T13:00:43+00:00September 17th, 2025|Endpoints News|
FDA calls out Hims and other telehealth companies for GLP-1 advertisingnews2025-09-17T13:00:37+00:00September 17th, 2025|Endpoints News|
